INSIGHTS ON FACILITY DESIGN
6 Misconceptions About Automating Cell Therapy Manufacturing
To help you move into a digitized world, here are six common misconceptions that can potentially hinder your ability to successfully execute an MES for cell therapy.
You Are Never Too Small To Think Big!
Your automation platform can expand with your business if you consider design choices in the initial stages. Early platform design choices can greatly affect speed to market and regulatory compliance.
Standardization Is Key To Building A Successful Global Business Strategy
Standardized approaches to biomanufacturing can lower costs, improve outcomes and alter the landscape of the global pharmaceutical market.
The Economics Of Biomanufacturing Strategies: Can You Afford Failure?
Prior to making critical strategy decisions, a small biotech company completed an economic evaluation of manufacturing options to ensure it was selecting the best fit for its drug development needs. Discover the critical elements of this analysis that may help to balance your expansion outlook.
Making Data Work
What is big data? What is Bioprocess 4.0? How do you leverage data to make better informed decisions? This video explores the role data plays in biopharma scale-up and manufacturing. Learn how to make data work for you.
When Clean Is Critical—Understanding Parameters And Definitions Of Clean
Clean room environments necessitate high-quality materials and equipment that conform to a variety of specified standards. This white paper explains how clean parameters are defined and validated.
Flexible Manufacturing: Better, Faster Virus Production
The global vaccine market is growing due to population growth, emerging pathogens and pandemics. The increased demand has led to new vaccines, manufacturing facility projects and increasing investments. Using flexible manufacturing strategies can help meet this growing vaccine demand.
Automating Cell Therapy Manufacturing For GMP Compliance And Consistency
Exploring the use of automation in cell therapy and advanced therapeutic medicinal product manufacturing to improve safety, quality, and compliance is a key factor in advancing patient care.
Facility Intensification And Cost Reduction Using An Integrated Buffer Delivery Platform
Outsourcing or implementing a streamlined buffer preparation and management systems allows biomanufacturers to considerably reduce floor usage, labor and costs. In this webinar, we will explore the benefits of an Integrated Buffer Delivery Platform.
FACILITY DESIGN SOLUTIONS
As the biopharma industry identifies faster and more efficient ways to deliver drugs to patients, such as break-through and fast track designations for accelerated approval, these progresses create pressure on both large and small drug manufacturers. As development timelines shorten, decisions related to drug commercialization need to be taken earlier, when key results are not yet available. And deciding on the scale and type of facility to build without complete data can create substantial risks with costly consequences.
GE Life Sciences Overview - Cell Processing
Helping your cell therapies succeed through our reach and resources.
Genderless AseptiQuik® L Series Connectors
Genderless AseptiQuik® Large Format 3/4", 1" and 1½" sanitary Connectors enable quick and easy sterile connections, even in non-sterile environments. The easy-to-use genderless design simplifies system integration and minimizes the risk of operator error. The connector's robust construction provides enhanced user confidence and reliable performance without the need for clamps, fixtures or tube welders. Biopharmaceutical manufacturers benefit from a full range of interchangeable 3/4" to 1½" flow solutions for production environments with the quality and market availability they expect from the leader in single-use connection technology.
Genderless AseptiQuik® L Series Connectors Datasheet
Genderless AseptiQuik® L Connectors enable quick and easy sterile connections, in large-volume, high-flow production environments. The largeformat, 3/4" and 1" genderless design simplifies system integration and minimizes the risk of operator error.
Transformations In Biomanufacturing
In biomanufacturing the only certainty is risk and the only constant is change. Technology is pushing new frontiers, new markets are opening up across the globe, and new competition is creating new levels of urgency—all under the ever more watchful eye of regulators.